product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
NEDD8 (19E3) Rabbit mAb
catalog :
2754
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
19E3
reactivity :
human, mouse, rat, cow
application :
western blot, immunohistochemistry, immunoprecipitation, flow cytometry
more info or order :
citations: 5
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6:14796-813 pubmed
|
| |
product information
SKU :
2754P
Product-Name :
NEDD8 (19E3) Rabbit mAb
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H, M, R, Mk, (X, Z, B)
Applications :
Flow cytometry
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
9
Host :
Rabbit
Target :
NEDD8
Primary-Protein :
NEDD8
Alt-Names :
FLJ43224,MGC104393,MGC125896,MGC125897,NEDD-8,NEDD8,Neddylin,Neural precursor cell expressed developmentally down-regulated protein 8,Ubiquitin-like protein Nedd8,neural precursor cell expressed, developmentally down-regulated 8
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
related products
browse more products
questions and comments